MLL REARRANGEMENT
Clinical trials for MLL REARRANGEMENT explained in plain language.
Never miss a new study
Get alerted when new MLL REARRANGEMENT trials appear
Sign up with your email to follow new studies for MLL REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia: experimental combo enters human testing
Disease control Recruiting nowThis early-stage study tests the safety of a new drug called ziftomenib when combined with standard chemotherapy for people whose acute myeloid leukemia (AML) has returned or not responded to treatment. The study includes adults with specific genetic changes (NPM1 mutation or KMT…
Matched conditions: MLL REARRANGEMENT
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 17, 2026 02:53 UTC
-
Stem cell test may forecast leukemia return
Knowledge-focused Recruiting nowThis observational study looks at whether leukemia stem cells can help predict if acute myeloid leukemia (AML) with MLL rearrangement will come back. Researchers will measure these stem cells in bone marrow samples taken during regular check-ups. The goal is to improve relapse pr…
Matched conditions: MLL REARRANGEMENT
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC